Picture of Biohaven Pharmaceutical Holding logo

BHVN Biohaven Pharmaceutical Holding Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapMomentum Trap

Annual cashflow statement for Biohaven Pharmaceutical Holding, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-127-241-529-769-848
Depreciation
Deferred Taxes
Non-Cash Items31.837111163209
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital0.5836.7941-107-217
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-94.8-197-377-703-831
Capital Expenditures-0.541-4.17-2.53-43.9-1.72
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-6.5-6.38-1.25-22628.3
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-7.04-10.5-3.78-27026.6
Financing Cash Flow Items-5.66103-1.15205100
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities210340435789845
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash10813353.5-18340.1

Or unlock with your email

Or unlock with your email